Cargando…

Analysis of Linear Antibody Epitopes on Factor H and CFHR1 Using Sera of Patients with Autoimmune Atypical Hemolytic Uremic Syndrome

INTRODUCTION: In autoimmune atypical hemolytic uremic syndrome (aHUS), the complement regulator factor H (FH) is blocked by FH autoantibodies, while 90% of the patients carry a homozygous deletion of its homolog complement FH-related protein 1 (CFHR1). The functional consequence of FH-blockade is wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trojnár, Eszter, Józsi, Mihály, Uray, Katalin, Csuka, Dorottya, Szilágyi, Ágnes, Milosevic, Danko, Stojanović, Vesna D., Spasojević, Brankica, Rusai, Krisztina, Müller, Thomas, Arbeiter, Klaus, Kelen, Kata, Szabó, Attila J., Reusz, György S., Hyvärinen, Satu, Jokiranta, T. Sakari, Prohászka, Zoltán
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371605/ https://www.ncbi.nlm.nih.gov/pubmed/28424685 http://dx.doi.org/10.3389/fimmu.2017.00302

Ejemplares similares

Autoantibodies Against the Complement Regulator Factor H in the Serum of Patients With Neuromyelitis Optica Spectrum Disorder
por: Uzonyi, Barbara, et al.
Publicado: (2021)

The Major Autoantibody Epitope on Factor H in Atypical Hemolytic Uremic Syndrome Is Structurally Different from Its Homologous Site in Factor H-related Protein 1, Supporting a Novel Model for Induction of Autoimmunity in This Disease
por: Bhattacharjee, Arnab, et al.
Publicado: (2015)

Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies
por: Trojnar, Eszter, et al.
Publicado: (2019)

FHR-5 Serum Levels and CFHR5 Genetic Variations in Patients With Immune Complex-Mediated Membranoproliferative Glomerulonephritis and C3-Glomerulopathy
por: Garam, Nóra, et al.
Publicado: (2021)

Minor Role of Plasminogen in Complement Activation on Cell Surfaces
por: Hyvärinen, Satu, et al.
Publicado: (2015)

Functional Characterization of the Disease-Associated N-Terminal Complement Factor H Mutation W198R
por: Cserhalmi, Marcell, et al.
Publicado: (2017)

Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic Syndrome
por: Zipfel, Peter F, et al.
Publicado: (2007)

Atypical HUS and Crohn’s disease—interference of intestinal disease activity with complement-blocking treatment
por: Horváth, Orsolya, et al.
Publicado: (2021)

Complement Factor H-Related Protein 4A Is the Dominant Circulating Splice Variant of CFHR4
por: Pouw, Richard B., et al.
Publicado: (2018)

First-line therapy in atypical hemolytic uremic syndrome: consideration on infants with a poor prognosis
por: Szarvas, Nóra, et al.
Publicado: (2014)

A case report of a child with sepsis induced multiorgan failure and massive complement consumption treated with a short course of Eculizumab: A case of crosstalk between coagulation and complement?
por: Galic, Slobodan, et al.
Publicado: (2019)

Immunosuppressive Therapy of Antibody-Mediated aHUS and TTP
por: Kelen, Kata, et al.
Publicado: (2023)

Neutrophil activation during attacks in patients with hereditary angioedema due to C1-inhibitor deficiency
por: Veszeli, Nóra, et al.
Publicado: (2015)

MCPggaac haplotype is associated with poor graft survival in kidney transplant recipients with de novo thrombotic microangiopathy
por: Petr, Vojtech, et al.
Publicado: (2022)

Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report
por: Rysava, Romana, et al.
Publicado: (2022)

Determining the Population Frequency of the CFHR3/CFHR1 Deletion at 1q32
por: Holmes, Lucy V., et al.
Publicado: (2013)

Efficacy of Eculizumab in a Patient With Immunoadsorption-Dependent Catastrophic Antiphospholipid Syndrome: A Case Report
por: Kronbichler, Andreas, et al.
Publicado: (2014)

Associations of CFH Polymorphisms and CFHR1-CFHR3 Deletion with Blood Pressure and Hypertension in Chinese Population
por: Gan, Wei, et al.
Publicado: (2012)

Novel CFHR2-CFHR1 Hybrid in C3 Glomerulopathy Identified by Genomic Structural Variation Analysis
por: Sugawara, Yuka, et al.
Publicado: (2019)

Atypical haemolytic uremic syndrome with refractory multiorgan involvement and heterozygous CFHR1/CFHR3 gene deletion
por: Diep, Jason, et al.
Publicado: (2023)

Complement Factor H-Related Proteins CFHR2 and CFHR5 Represent Novel Ligands for the Infection-Associated CRASP Proteins of Borrelia burgdorferi
por: Siegel, Corinna, et al.
Publicado: (2010)

Common haplotypes at the CFH locus and low-frequency variants in CFHR2 and CFHR5 associate with systemic FHR concentrations and age-related macular degeneration
por: Lorés-Motta, Laura, et al.
Publicado: (2021)

Decreased Ficolin-3-mediated Complement Lectin Pathway Activation and Alternative Pathway Amplification During Bacterial Infections in Patients With Type 2 Diabetes Mellitus
por: Barkai, László József, et al.
Publicado: (2019)

Regulating complement in the kidney: insights from CFHR5 nephropathy
por: Gale, Daniel P., et al.
Publicado: (2011)

CFHR1 is a potentially downregulated gene in lung adenocarcinoma
por: Wu, Geting, et al.
Publicado: (2019)

Atypical HUS Associated with CFH/CFHR-1 Hybrid Gene
por: Negi, Sharon, et al.
Publicado: (2020)

Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma
por: Ding, Qinglin, et al.
Publicado: (2022)

Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies
por: Münch, Johannes, et al.
Publicado: (2017)

Complement Genetic Variants and FH Desialylation in S. pneumoniae-Haemolytic Uraemic Syndrome
por: Gómez Delgado, Irene, et al.
Publicado: (2021)

Follow-Up of Blood Pressure, Arterial Stiffness, and GFR in Pediatric Kidney Transplant Recipients
por: Végh, Anna, et al.
Publicado: (2021)

Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency
por: Csuka, Dorottya, et al.
Publicado: (2015)

Hemolytic uremic syndrome in the setting of COVID-19 successfully treated with complement inhibition therapy: An instructive case report of a previously healthy toddler and review of literature
por: Matošević, Matija, et al.
Publicado: (2023)

Overview of SERPING1 Variations Identified in Hungarian Patients With Hereditary Angioedema
por: Szabó, Edina, et al.
Publicado: (2022)

Factor H Family Proteins in Complement Evasion of Microorganisms
por: Józsi, Mihály
Publicado: (2017)

Pregnancy in Complement-Mediated Thrombotic Microangiopathy: Maternal and Neonatal Outcomes
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2023)

Diagnosing Pediatric Patients With Hereditary C1-Inhibitor Deficiency—Experience From the Hungarian Angioedema Center of Reference and Excellence
por: Andrási, Noémi, et al.
Publicado: (2022)

Human Pentraxin 3 Binds to the Complement Regulator C4b-Binding Protein
por: Braunschweig, Anne, et al.
Publicado: (2011)

Editorial: Updates on the complement system in kidney diseases
por: Bulla, Roberta, et al.
Publicado: (2023)

Non-lupus full-house nephropathy—immune dysregulation as a rare cause of pediatric nephrotic syndrome: Questions
por: Horváth, Orsolya, et al.
Publicado: (2021)

Non-lupus full-house nephropathy—immune dysregulation as a rare cause of pediatric nephrotic syndrome: Answers
por: Horváth, Orsolya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d2d8kog7gohl711et00t10qvqp